Nair Vinay’s Sage Therapeutics SAGE Stock Holding History

Nair Vinay’s Portfolio SAGE Stock Details SAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-5,025	Closed	-$252K	–	309
2015 Q1	$252K	Buy	+5,025	New	+$216K	0.18%	245

Other funds holding SAGE

TRV

Third Rock Ventures Boston, Massachusetts $1.07B AUM 170.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Nair Vinay's SAGE Position: Q2 2015 in Review

Nair Vinay sold out of Sage Therapeutics (SAGE) in Q2 2015, closing a stake of 5,025 shares — an estimated $252K sold.

Nair Vinay first reported a position in SAGE in Q1 2015 and held it in 1 quarter. The position peaked at $252K in Q1 2015. 124 funds tracked by Wall St. Rank hold SAGE as of Q2 2015.

Nair Vinay reported no remaining Sage Therapeutics position as of Q2 2015 after selling out during the quarter.
Nair Vinay sold 5,025 Sage Therapeutics shares in Q2 2015, an estimated $252K.
Nair Vinay first reported a position in Sage Therapeutics in Q1 2015 and held it in 1 quarter.
Nair Vinay's Sage Therapeutics position peaked at $252K in Q1 2015.
124 funds tracked by Wall St. Rank held Sage Therapeutics as of Q2 2015.

Based on Nair Vinay's 13F filing for Q2 2015, filed 12 Aug 2015.